[New thrombolytic agents. Thrombin and factor Xa inhibitors].
Heinzl
S
S
sheinzl@wissen-schaftliche-verlagsgesellschaft.de
D002986:Clinical Trials as Topic; D017326:Clinical Trials, Phase III as Topic; D015195:Drug Design; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D013917:Thrombin / Q000037:antagonists & inhibitors*
D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D013917:Thrombin